Morning Market Digest: Aug 26, 2026
ABCL leads early gainers at +17.81%; DKS leads decliners at -30.68%.
- ABCL leads the gainers screen at +17.81%.
- DKS leads the decliners screen at -30.68%.
Daily stock-market updates without the noise
Ticker Times
A morning digest before the open, then concise updates on key earnings, filings, and ticker moves as the day develops.
Earnings, filings, and market-moving ticker notes.
Dycom Industries, Inc. (DY) was observed in the linked market data trading lower -11.62% at $310.91.
Spyre Therapeutics, Inc. (SYRE) was observed in the linked market data trading lower -12.81% at $93.61.
Biohaven Ltd. (BHVN) was observed in the linked market data trading higher +21.91% at $17.53.
Generate Biomedicines, Inc. (GENB) was observed in the linked market data trading lower -17.86% at $16.74.
Abercrombie & Fitch Company (ANF) was observed in the linked market data trading higher +40.47% at $152.97.
KANZHUN LIMITED - American Depo (BZ) was observed in the linked market data trading higher +16.54% at $18.98.
ABCL leads early gainers at +17.81%; DKS leads decliners at -30.68%.
TOP leads early gainers at +14.93%; AAOI leads decliners at -13.77%.
SLS leads early gainers at +15.37%; IESC leads decliners at -49.87%.
MARA leads early gainers at +15.54%; MRNA leads decliners at -23.55%.
Dycom Industries, Inc. (DY) was observed in the linked market data trading lower -11.62% at $310.91.
Spyre Therapeutics, Inc. (SYRE) was observed in the linked market data trading lower -12.81% at $93.61.
Biohaven Ltd. (BHVN) was observed in the linked market data trading higher +21.91% at $17.53.
Generate Biomedicines, Inc. (GENB) was observed in the linked market data trading lower -17.86% at $16.74.
Price changes and reported volume come from the market-data sources linked on each article. They are snapshots, not forecasts.
A price move is not evidence of its cause. If the linked sources do not identify a company-specific catalyst, the article says so rather than inferring one.
Every automated article preserves source attribution and separates sourced facts from items readers may want to verify. Coverage is informational only and is not investment advice.